Clinical Severity of Clostridium difficile PCR Ribotype 027: A Case-Case Study
Oliver W. Morgan, Boaventura Rodrigues, Tony Elston et al. · 2008
Read Clinical Severity of Clostridium difficile PCR Ribotype 027: A Case-Case Study by Oliver W. Morgan, Boaventura Rodrigues, Tony Elston et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001812.txt.
Introduction
Oliver W. Morgan, Boaventura Rodrigues, Tony Elston, and their co-authors studied how severe a dangerous gut infection strain is in a 2008 PLOS ONE research article. Clostridium difficile is a leading cause of diarrhoea tied to health care. Several rich countries had reported more cases and outbreaks, blamed on the new PCR ribotype 027 strain.
Their study compared how sick ribotype 027 patients got with patients infected by other types. The full text gives the patient groups and how each group fared. Whether 027 is truly more harmful, or just more common, decides how hospitals should spend on separate rooms and testing for this strain.
Catalog record
| CREATOR | Oliver W. Morgan, Boaventura Rodrigues, Tony Elston et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001812
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Clinical Severity of Clostridium difficile PCR Ribotype 027: A Case-Case Study Authors: Oliver W. Morgan, Boaventura Rodrigues, Tony Elston, Neville Q. Verlander, Derek F. J. Brown, Jonathan Brazier, Mark Reacher Published: 2008, PLOS ONE DOI: 10.1371/journal.pone.0001812 ABSTRACT Clostridium difficile is a leading infectious cause of health care associated diarrhoea. Several industrialised countries have reported increased C. difficile infections and outbreaks, which have been attributed to the emergent PCR ribotype 027 strain. We conducted a case-case study to compare severity of C. difficile disease for patients with 027 versus non-027 ribotypes. We retrospectively collected clinical information about 123/136 patients with C. difficile infections admitted to hospitals in the East of England region in 2006 and from whom stool isolates were cultured and ribotyped as part of an earlier national survey. We defined severe C. difficile disease as having one or more of shock, paralytic ileus, pseudo membranous colitis or toxic megacolon. Patient median age was 83 years old (range 3 to 98, interquartile range 75 to 89), 86% were prescribed antibiotics in the eight weeks before illness onset, 41% had ribotype 027 and 30-day all cause mortality during hospital admission was 21%. Severe disease occurred in 24% (95%CI 13% to 37%) and 17% (95%CI 9% to 27%) of patients with PCR ribotype 027 and non-027 ribotypes respectively. In a multivariable model, ribotype 027 was not associated with severe disease after adjusting for sex, discharge from hospital prior to 60 days of current admission, gastroenteritis on admission, number of initiator antibiotics for C. difficile disease, and hospital where the patient was admitted. Our study found no evidence to support previous assertions that ribotype 027 is more virulent than other PCR ribotypes. This finding raises questions about the contribution of this strain to the recent increase in C. difficile disease throughout North America and Europe. INTRODUCTION Clostridium difficile is a Gram-positive spore forming anaerobic bacterium that is found in the normal gut flora of man. Clostridium difficile associated disease (CDAD) generally follows ingestion of antibiotics that leads to selection of toxin-producing strains, resulting in a leading infectious cause of health care associated diarrhoea [1] . CDAD ranges from mild uncomplicated diarrhoea to severe diarrhoea complicated by one or more of fluid loss, shock, leukocytosis, paralytic ileus, pseudomembranous colitis, and toxic megacolon, and sometimes death [2] . Prevention and control of CDAD crucially depends on maintaining high levels of institutional hygiene, including the prompt recognition and isolation of individuals with application of enteric precautions, and on minimising exposure to antibiotics [1] . Molecular typing of toxigenic strains of C. difficile based on detection of genes encoding toxins A and B within the pathogenicity locus ( PaLoc ) [3] , [4] has led to the recognition of at least 22 distinct toxinotypes [3] , [5] . Health systems in a number of industrialised countries have reported recent increases of C. difficile infections and outbreaks have been attributed to the emergence of a strain characterised as toxinotype III, North American pulsed-field type 1, PCR ribotype 027 [6] , [7] , [8] , [9] , [10] . It has been asserted that this strain is more virulent than other strains [3] , [11] , a notion supported by very high levels of toxin A and B production in vitro [11] . It is possible, however, that the impression of greater virulence of the 027 ribotype could reflect, at least in part, biases in the sampling, testing and reporting of cases. In this study, we examine whether patients with CDAD due to ribotype 027 had more severe disease than patients with CDAD caused by other ribotypes. METHODS We conducted a case-case study. This study design is a variant of the case-control design whereby only cases with the disease (in this case C. difficile ) are selected for the study [12] . Cases are grouped by subtype of infectious disease organism, in this case C. difficile 027 versus non-027 ribotypes, and their outcomes (here we consider clinical severity of disease) are compared. The advantage of using a case-case design is that it frequency matches on all aetiological factors, both known and unknown, and selects groups that are similar for disease-specific risk factors [13] . In this study, a case-case design provides a non-biased comparison of disease severity among patients with different strains of C. difficile . IDENTIFICATION OF PATIENTS We retrospectively identified inpatient cases of C. difficile from 16 National Health Service (NHS) hospitals in the East of England region included in a national survey of C. difficile PCR ribotypes, as reported elsewhere [14] , [15] . The survey selected all patients with CDAD detected by microbiology laboratories in the East of England during one allocated week between 9 January and 3 March 2006. Stool isolates from these patients were sent to the regional coordinating laboratory where anaerobic culture was undertaken. PCR ribotyping was done by the Health Protection Agency Anaerobe Reference Laboratory in Cardiff. DATA COLLECTION We developed a structured proforma to extract information from medical records about patients' demographic details; main diagnosis at admission; treatment during 8 weeks prior to diagnosis of suspected CDAD with antibiotics, H2 agonists and proton-pump inhibitors; C. difficile -related illness; and all cause mortality during hospital admission within 30-days of onset of CDAD. Data were extracted by medical microbiologists involved in patient care or by a member of the study team. Individuals who extracted data were not aware of the ribotyping results. Data were double-entered, compared and corrected using EpiData (v.3.1) software [16] . ANALYSIS We defined severe CDAD as having one or more of shock (systolic BP 100 mmHg or less at any time, and/or oliguria), paralytic ileus, pseudo membranous colitis or toxic megacolon. We considered the following risk factors: infection with 027 or non-027 ribotypes, age group (by quintile), sex, previous discharge from any hospital within 60 days prior to admission, having gastroenteritis at admission, being immunocompromised, use of proton pump inhibitors or H2 agonists within 8-weeks before diagnosis of CDAD, use of antibiotics in the 8-weeks before diagnosis of CDAD (where glycopeptides and metronidazole were considered protective against CDAD and all other antibiotics were considered as potential initiators of CDAD), and the hospital to which the patient was admitted. We conducted a single variable analysis wherein each risk factor was examined for its association with severe CDAD. Variables with probability p<0.3 in the single variable analysis were then entered into a multivariable logistic regression model. The variable for hospital was included as a random effect in the analysis; all other variables were analysed as fixed effects. Analysis was done using STATA 9.1 [17] . ETHICAL APPROVAL The study protocol was approved by the Cambridge Local Research Ethics Committee (Ref: 06/Q0108/249). RESULTS There were 136 patients admitted to a hospital in the East of England with CDAD and from whom an isolate was included as part of the national survey of C. difficile . We were able to obtain clinical information for 123 patients (90%). There were slightly fewer males than females ( Table 1 ). The median age was 83 years old, with a range of 3 to 98 years old and interquartile range of 75 to 89 years old ( Table 1 ). The age distribution was skewed